Elimbosis - apixaban 2.5mg and 5 mg tablet

Product Description

Elimbosis 5 mg tab - apixaban 5 mg Pack: 30 tab
Category: is an anticoagulant.Indications: Apixaban is used for the following:
1-To lower the risk of stroke and embolism in people with non-valvular atrial fibrillation.
2-Deep vein thrombosis (DVT) prevention. DVTs may lead to pulmonary embolism (PE) in knee or hip replacement surgery patients.
3-Treatment of both DVT and PE.
4-To reduce the risk of recurring DVT and PE after initial therapy.

Zeta Pharma

  • EG
  • 2019
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Association/Government
Contract Service
Distributor/Import Export
OTC
Pharmaceutical company
Wholesale/Retail
Primary activities
Contract Manufacturer
End-product distributor (Wholesale)
Finished Formulation products Distributor/Buyer
Nutraceuticals
Pharmaceutical Company (generic finished products)
Regulatory Affairs
Specifications
  • Supplied from
    Egypt
  • Measured In
    milligram

Zeta Pharma

  • EG
  • 2019
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Association/Government
Contract Service
Distributor/Import Export
OTC
Pharmaceutical company
Wholesale/Retail
Primary activities
Contract Manufacturer
End-product distributor (Wholesale)
Finished Formulation products Distributor/Buyer
Nutraceuticals
Pharmaceutical Company (generic finished products)
Regulatory Affairs

More Products from Zeta Pharma (17)

  • BILASTIGEC - Bilastine 20mg tablet

    Product BILASTIGEC - Bilastine 20mg tablet

    BILASTIGEC - Bilastine 20mg tablet Pack: 10 tablet    
    Category: anti-allergic      
    Indication: allergic rhinoconjunctivitis and urticaria (hives)
  • Elimbosis-Apixaban

    Product Elimbosis-Apixaban

    Composition Each Elimbosis 2.5mg Film tablet contains: apixaban .......................... 5 mg Each Elimbosis 2.5mg Film tablet contains: apixaban .......................... 2.5 mg Therapeutic Indications ● Stroke Prophylaxis with Atrial Fibrillation ● Postoperative Prophylaxis of DVT/PE -DVT or PE Treatm...
  • Empacoza-empagliflozin

    Product Empacoza-empagliflozin

    empagliflozin.............................................. 10 mg empagliflozin.............................................. 25 mg Therapeutic Indications ● Type 2 Diabetes Mellitus ○ Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes ○ Also indicated t...
  • Nexicure mups-Esomeprazole

    Product Nexicure mups-Esomeprazole

    Each Nexicure 40mg Film Coated MUPS tablet contains: Esomeprazole ...... 40 mg Each Nexicure 20mg Film Coated MUPS tablet contains: ......................................... 20 mg Therapeutic Indications ● Gastroesophageal reflux disease’ (GERD) ● Erosive reflux oesophagitis. ● Treatment of Zollinger-Ellis...
  • Nexicure  - esomeprazole 40 mg and 20 mg MUPS tab

    Product Nexicure - esomeprazole 40 mg and 20 mg MUPS tab

    Nexicure 40 mg and 20mg MUPS tabPack: 20 tab
    Category: proton pump inhibitors (PPIs)The first and only PPI - Esmoperazole 40 mg and 20mg tab generic with MUPS technology 
    Indication: It is used to treat gastroesophageal reflux disease GERD, peptic ulcer disease, and&nbs...
  • Vonseca  - vonoprazan 10mg and 20 mg tab

    Product Vonseca - vonoprazan 10mg and 20 mg tab

     Vonoprazan is a potassium-competitive acid blocker (PCAB). It competitively inhibits the binding of K ions to hydrogen/potassium-adenosine triphosphate (H+/K+-ATPase) enzyme system that acts as the proton pump of the gastric parietal cell, thereby inhibiting gastric acid production belong to the prot...
  • Integrated Solution of Full Range of Empagliflozin in the management of type 2 diabetes.

    Product Integrated Solution of Full Range of Empagliflozin in the management of type 2 diabetes.

    Empagliflozin, a potent SGLT2 inhibitor, stands out in the management of type 2 diabetes (T2D). It reduces glucose reabsorption in the kidneys, leading to increased urinary glucose excretion. Studies highlight its efficacy as monotherapy, effectively lowering HbA1c levels and promoting weight loss, making ...
  • Nexicure Sachets, Esomeprazole Sachets: 2.5mg, 5mg, 10mg, and 20mg

    Product Nexicure Sachets, Esomeprazole Sachets: 2.5mg, 5mg, 10mg, and 20mg

    • Age Group for Every Concentration

    • 2.5mg: Suitable for infants and children aged 1 month to less than 1 year. • 5mg: Recommended for children aged 1 to 5 years. • 10mg: Suitable for children aged 6 to 11 years. • 20mg: Designed for adolescents aged 12 years and older, as well as adults. ...
  • Sofocivir Plus -  (ledipasvir 90 mg/sofosbuvir 400 mg) tablets

    Product Sofocivir Plus - (ledipasvir 90 mg/sofosbuvir 400 mg) tablets

    Sofocivir Plus -  (ledipasvir 90 mg/sofosbuvir 400 mg) tabletsPack: 28 tab
    Category: Direct Anti-viral - DAA's - Ledipasvir belong to NS5A Inhibitors
    Indication: used to treat hepatitis C. 
    Dose: It is taken daily by mouth for 8–24 weeks.[
  • Sofocivir - Sofosbuvir 400 mg tab

    Product Sofocivir - Sofosbuvir 400 mg tab

    Sofocivir:Pack: 28 tab
    Category: Direct Anti-viral DAA's belong to Nucleoside and Nucleotide NS5B Polymerase Inhibitors
    Indication: used for the treatment of hepatitis C.
  • Zetaciver - Daclatasvir 60 mg tab

    Product Zetaciver - Daclatasvir 60 mg tab

    Daclatasvir:Pack: 28 tab
    Category: Direct Anti-viral DAA's - belong to NS5A Inhibitors
    Indication: used for the treatment of hepatitis C.
  • NORPREGNA ULIPRISTAL ACETATE 30 mg

    Product NORPREGNA ULIPRISTAL ACETATE 30 mg

    NORPREGNA Each tablet contains 30 mg ulipristal acetate. Pack: 2 tablet
    Category: Emergency contraceptive
    Indications: NORPREGNA indicated as Emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure

Zeta Pharma resources (1)

  • Brochure Zeta Pharma Company Profile

     ZETA PHARMA® is the leading branded generic from Egypt

    ZETA PHARMA®, established in 2010, brings significant value to the  pharmaceutical industry in Egypt, Africa, Middle East and CIS regions.

    ZETA PHARMA® is the fastest-growing company in the top 100 Egyptian pharmaceutical companies during the last 4 years with CAGR % 112 ( IQVIA.)

    ZETA PHARMA® boasts a state-of-the-art manufacturing facility built to WHO cGMP standards.

    ZETA PHARMA®, in a groundbreaking partnership with the European Bank for Reconstruction and Development (EBRD), has embarked on an ambitious project to secure EMA accreditation. This endeavor underscores our unwavering commitment to excellence and innovation, setting new standards in the pharmaceutical industry.

    ZETA PHARMA®, offer advanced manufacturing meets cutting-edge pharmaceutical solutions, empowering health and wellness across the globe...